Estimadas y estimados colegas, 

Les comparto información sobre este webinar que está organizando el comité de Inmunoterapia de la IUIS para aquellos que pudiera interesarles. Adjunto el flyer y la información disponible en la web de la IUIS 

https://iuis.org/events/iuis-immunotherapy-committee-presents-harnessing-the-tme-to-enhance-the-classification-of-tumors/

INFORMATION ABOUT THE EVENT

This webinar will discuss groundbreaking advancements in immune mapping of human tumor lesions, providing insights into their impact on clinical practice. We will also examine the opportunities, challenges, and emerging trends in immune-based tumor classification, with a focus on enhancing immunotherapy decision-making.

The goal of this exciting webinar is to:

• Disseminating state-of-the-art knowledge on major topics covered by immunotherapy in Medicine and Science
• Discussing current challenges and unmet needs faced by clinicians and patients
• Promoting scientific dialogue and collaboration to spark innovation and drive progress in the field

So it will be beneficial for all the MD and PhD trainees in cancer Immunology and Clinicians and Researchers working in fields related to Cancer Immunotherapy in Academic, Clinical and Industry settings.

Register Here!

We will welcome an excellent line up of speakers:

• Intro by moderators: Thomas Marron MD and Jennifer Giltnane MD
• Toward an immunopathological classification of tumours by Jenis Taube MD
• Immune mapping of tumour lesions by Herve Fridman MD
• Roundtable discussion and Q&A moderated by Thomas Marron MD and Jennifer Giltnane MD